NeuroPace, Inc.

NASDAQ (USD): NeuroPace, Inc. (NPCE)

Last Price

11.84

Today's Change

-0.27 (2.22%)

Day's Change

11.75 - 12.65

Trading Volume

78,357

Profile
NPCE

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Joel D. Becker Mr. Joel D. Becker

Full Time Employees:  184 184

IPO Date:  2021-04-22 2021-04-22

CIK:  0001528287 0001528287

ISIN:  US6412881053 US6412881053

CUSIP:  641288105 641288105

Beta:  1.80 1.80

Last Dividend:  0.00 0.00

Dcf Diff:  14.01 14.01

Dcf:  -0.02 -0.02

Description

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.

Address

455 North Bernardo Avenue,
Mountain View, CA 94043, US

650 237 2700

http://www.neuropace.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment